MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.47 -0.23 (-1.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Interest Coverage Ratio (2022 - 2026)

Updated

MoonLake Immunotherapeutics' Interest Coverage Ratio came in at -23.43 for Q2 2026, compared with -29.80 a year earlier.

Analysis

MoonLake Immunotherapeutics (MLTX) Interest Coverage Ratio (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, MoonLake Immunotherapeutics reported Interest Coverage Ratio of -26.59; for FY2025, it came in at -33.78.

  • The five-year range for quarterly Interest Coverage Ratio is -24265.32 (Q1 2022) to -22.34 (Q3 2025).
  • Business Quant data shows MLTX's Interest Coverage Ratio at -30.86 (Q1 2026), -32.71 (Q4 2025) and -22.34 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - -23.43
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.43
Mar 31, 2026 -30.86
Dec 31, 2025 -32.71
Sep 30, 2025 -22.34
Jun 30, 2025 -29.80
Mar 31, 2025 -2,638.06
Mar 31, 2022 -24,265.32
API Access

MoonLake Immunotherapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=MLTX&period=max&api_key=YOUR_API_KEY